摘要
肿瘤免疫疗法是目前肿瘤治疗的研究热点,因其疗效显著而备受瞩目。免疫检查点阻断疗法是众多免疫疗法的有效策略之一,其中以PD-1/PD-L1和CTLA-4为代表的免疫检查点抑制剂在黑色素瘤等实体肿瘤治疗中取得了令人振奋的结果。本文对免疫检查点阻断疗法的进展及该领域中亟需解决的问题做一分析和展望。
Tumor immunotherapy is highlighted in tumor studies and has drawn a great attention due to its success. Immune checkpoint blockade therapy is one of the effective strategies among numerous immunotherapies. Immune checkpoint inhibitors like PD-1/PD-L1 and CTLA-4 have achieved exciting results in melanoma and other solid tumors. In this review, we mainly discuss the progress in immune checkpoint blockade therapy, and problems that need to be solved.
作者
祝玲
路君
王水良
谭建明
Zhu Ling Lu Jun Wang Shuiliang Tan Jianming.(Fujian Key Laboratory of Transplant Biology, Fuzhou General Hospital, Fuzhou 350025, Chin)
出处
《中华细胞与干细胞杂志(电子版)》
2016年第6期388-390,共3页
Chinese Journal of Cell and Stem Cell(Electronic Edition)
关键词
肿瘤
免疫疗法
免疫检查点
Tumor
Immunotherapy
Immune checkpoint